BUECHLER KENNETH F 4

What Happened Kenneth F. Buechler, a director of QuidelOrtho Corporation, received the release of 2,156 restricted stock units (RSUs) that converted into 2,156 shares on June 6, 2026. The Form 4 shows two award/acquisition entries for 1,659 and 497 shares at $0.00 and corresponding exercise/conversion (derivative) entries at $0.00. Total value reported for these transactions is $0 (no purchase price paid).

Key Details

• Transaction date: 2026-06-06; Form 4 filed 2026-06-09 (filing appears timely).
• Shares released/converted: 1,659 RSUs + 497 RSUs = 2,156 shares.
• Price: $0.00 per share (RSU release/conversion, not a cash purchase or sale).
• Shares owned after transaction: Not specified in the provided filing data.
• Footnotes:
  • F1: Release of RSUs that were previously reported on a Form 4.
  • F2: Each RSU equals the right to one share of common stock.
  • F3: RSU release was deferred under QuidelOrtho’s deferred compensation program for non-employee directors and occurred per the elected deferred schedule.
• Transaction codes: A = Award/Acquisition; M = Exercise/conversion of derivative (here, RSUs converting to common stock). These M entries are conversions, not sales.

Context This was a compensation-related release/conversion of deferred RSUs for a non-employee director, a routine corporate action rather than an open-market purchase or sale. Such releases reflect previously granted compensation converting into shares and do not by themselves indicate a director buying or selling stock for trading purposes.